site stats Cyteph Completes Recruitment for Phase I Clinical Trial of CYT-101 in Patients with Recurrent Glioblastoma Multiforme Brain Cancer – Posopolis

Cyteph Completes Recruitment for Phase I Clinical Trial of CYT-101 in Patients with Recurrent Glioblastoma Multiforme Brain Cancer

PressBee – BRISBANE, Australia, Oct. 7, 2025 /PRNewswire/ — Cyteph Pty Ltd, a biotechnology company developing novel immunotherapies for difficult-to-treat cancers,

About admin